Anna C. Bibby
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Pleural and Pulmonary Diseases 23
- Occupational and environmental lung diseases 21
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 5
- Medical Imaging and Pathology Studies 3
- Lung Cancer Diagnosis and Treatment 3
-
- Ultrasound in Clinical Applications 2
- Co-authors
- Nick A. Maskell (28 shared papers)Ioannis Psallidas (5 shared papers)Anna J. Morley (6 shared papers)Kevin G. Blyth (6 shared papers)Selina Tsim (3 shared papers)Nikolaos I. Kanellakis (2 shared papers)Denis Charles Talbot (1 shared paper)Hannah Ball (1 shared paper)
- Journals
- The Lancet (6 papers)Thorax (4 papers)European Respiratory Journal (3 papers)CHEST Journal (3 papers)BMJ Open (2 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Anna C. Bibby
51 papers receiving 3.5k citations
Anna C. Bibby's Hit Papers
Peers
Comparison fields: 5 of 120
- Critical Care and Intensive Care Medicine 338
- Infectious Diseases 1.1k
- Neurology 752
- Pulmonary and Respiratory Medicine 1.4k
- Applied Microbiology and Biotechnology 50
Countries citing papers authored by Anna C. Bibby
This map shows the geographic impact of Anna C. Bibby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna C. Bibby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna C. Bibby more than expected).
Fields of papers citing papers by Anna C. Bibby
This network shows the impact of papers produced by Anna C. Bibby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna C. Bibby. The network helps show where Anna C. Bibby may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna C. Bibby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort Hit paper breakdown → | 2020 | 467 |
| 2 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 3 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 4 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 5 | Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19 Hit paper breakdown → | 2022 | 250 |
| 6 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 7 | 2016 | 227 | |
| 8 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 9 | 2018 | 205 | |
| 10 | 2018 | 179 | |
| 11 | British Thoracic Society Guideline for pleural disease Hit paper breakdown → | 2023 | 146 |
| 12 | 2018 | 88 | |
| 13 | 2018 | 88 | |
| 14 | 2023 | 85 | |
| 15 | 2023 | 83 | |
| 16 | 2016 | 33 | |
| 17 | 2014 | 31 | |
| 18 | 2019 | 25 | |
| 19 | 2018 | 22 | |
| 20 | 2019 | 20 |
About Anna C. Bibby
Anna C. Bibby is a scholar working on Pulmonary and Respiratory Medicine, Critical Care and Intensive Care Medicine, Infectious Diseases, Surgery and Neurology, having authored 51 papers that have together received 3.6k indexed citations. Recurring topics across this work include Pleural and Pulmonary Diseases (23 papers), Occupational and environmental lung diseases (21 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Trauma Management and Diagnosis (4 papers), Medical Imaging and Pathology Studies (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Ultrasound in Clinical Applications (2 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (338 citations), Infectious Diseases (1.1k citations), Neurology (752 citations), Pulmonary and Respiratory Medicine (1.4k citations) and Applied Microbiology and Biotechnology (50 citations). Anna C. Bibby has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Nick A. Maskell, Ioannis Psallidas, Anna J. Morley, Kevin G. Blyth, Selina Tsim, Nikolaos I. Kanellakis, Denis Charles Talbot, Hannah Ball, David Arnold and Shaney Louise Barratt. Their work appears in journals such as The Lancet, Thorax, European Respiratory Journal, CHEST Journal and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.